Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
drug development
3
×
ipo
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
vc
3
×
venture capital
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
fundraising
indiana blog main
indiana top stories
laura shawver
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
ac immune
accent therapeutics
acquisition
What
bio
ipo
roundup
activity
advance
approvals
biogen
biology
biopharma
car
celgene
clamped
colleagues
company
covid
cytokine
delays
developing
drugs
economic
enhanced
exome
fast
fda
files
government
health
hundreds
including
industry
initial
isn’t
laying
lot
medicine
medicines
money
new
offering
oric’s
Language
unset
Current search:
vc
×
" boston blog main "
×
" drug development "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
